(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl-3-amino-2,3,6-tridesoxy-4-O-[(2S)-tetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosid
RxNorm 33764· ATC L01DB08· pirarubicin
KR · 한국Produkte in Korea (5)
- 동아피노루빈주20밀리그람(피라루비신)동아에스티(주)
- 동아피노루빈주20밀리그람(피라루비신)동아에스티(주)
- 동아피노루빈주20밀리그람(피라루비신)동아에스티(주)
- 동아피노루빈주20밀리그람(피라루비신)동아에스티(주)
- 동아피노루빈주20밀리그람(피라루비신)동아에스티(주)
Chemie (PubChem)
- Summenformel
- C32H37NO12
- Molekülmasse
- 627.6 g/mol
- IUPAC-Name
- (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-6-methyl-5-[(2R)-oxan-2-yl]oxyoxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
- InChIKey
- KMSKQZKKOZQFFG-YXRRJAAWSA-N